From Breakthroughs Blog: WHO

 
PATH/Gabe Bienczycki
Research Roundup: WHO unveils online resource to guide neglected disease R&D, major funding announcements for snakebite research, and TB Alliance awarded grants to develop TB drug candidates

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Georgina Goodwin
Research Roundup: Warning to address drug-resistant TB, a new Ebola vaccine strategy in DRC, and FDA takes step to bolster research on pregnant and lactating women

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Gabe Bienczycki
Innovating the way towards UHC at WHA

Universal health coverage (UHC) will take center stage at the World Health Assembly later this month. While there are many building blocks to achieve UHC, one integral pillar that is too often overlooked is innovation—the creation of new and improved drugs, vaccines, and diagnostic tools. Global health research and development is indispensable in delivering on the vision of quality health for all.

GHTC
Read More
PATH/Doune Porter
Research Roundup: World's first malaria vaccine, how to shape research to advance global health, and lotion that protects from malaria

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Eric Becker
Research Roundup: WHO transformations, new funding model for health needed, and HIV reported cured in second patient

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
Flickr/United States Mission Geneva, Eric Bridiers
WHO EB moves forward actions on budget, access to medicines, and AMR R&D

The 2019 global health multilateral calendar kicked off as it always does with the World Health Organization (WHO) Executive Board (EB) meeting in late January in Geneva. This year’s session featured a packed agenda with significant implications for research and development.

Read More
PATH/Felix Masi
Research Roundup: SFOPs funding for FY19, Lassa fever outbreak in West Africa, and new TB drug may shorten treatment time

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
UN Photo/Loey Felipe
Overheard at UNGA: 4 key takeaways on global health innovation

A “who’s who” of politicians, philanthropists, CEOs, and civil society leaders descended upon New York City this week for the annual United Nations General Assembly (UNGA). GHTC was there, serving as your eyes and ears on the ground. Here is what we heard and our top four takeaways on global health R&D.

Read More
PATH/Wendy Stone
Research Roundup: US launches biodefense strategy, TB remains world's top infectious killer, and human trials begin for antimalarial drug

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
WHO/L. Cipriani
WHA Roundup: Incremental steps forward on access and TB takes the limelight

What global health research advocates need to know about the 71st World Health Assembly (WHA).

Read More
Pan American Health Organization
What to watch at WHA 71

The 71st session of the World Health Assembly will see a number of debates that could impact global health R&D. Here is is what you need to know.

Read More
GHTC/Matt Robinson
WHO Executive Board approves actions on access to medicine and intellectual property

Last week’s World Health Organization (WHO) Executive Board meeting featured agenda items on access to medicines and intellectual property. We cover how debates on these items shook out:

Read More
PATH/Aaron Joel Santos
Five issues to watch in US global health R&D policy in 2018

2018 is shaping up to be another important year for US policy related to global health and medical research. As Congress returns for a busy work session and the White House continues to roll out policy reforms, here are the top five issues GHTC will be following in 2018.

GHTC
Read More
PATH/Carib Nelson
Research Roundup: Unlocking a malaria mystery, WHO prequalifies new typhoid vaccine, and the power of vitamin C

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Lynn Heinisch
Research Roundup: Improved Ebola & malaria diagnostics and gene therapy to foster HIV immunity

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
Photo courtesy Bill & Melinda Gates Foundation/Lou Linwei
Research Roundup: A mosquito deliverer, the "fake" medicine crisis, and a promising typhoid vaccine

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week

GHTC
Read More
PATH/Gabe Bienczycki
Research Roundup: An old-fashioned malaria strategy, a polio funding crisis, and a global pledge to end TB

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Heng Chivoan
Research Roundup: Wearable immunization trackers, a potential pneumonia vaccine, and a newly recommended typhoid vaccine

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Rocky Prajapati
Research Roundup: The immunization edition

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Gabe Bienczycki
Research Roundup: Nanopatch technology, agriculture and antibiotics, and a first-time pledge

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
GHTC/Taylor Capizola
Overheard at UNGA: Innovation paves path to universal health coverage

A busy week at the 72nd United Nations General Assembly winds to a close with key discussions surrounding the global economic returns of health R&D.

Read More
CDC/ Sue Partridge, CDC- Ft. Collins
Research Roundup: Global immunization, Zika diagnostics, and an HIV treatment milestone

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Mike Wang
Research Roundup: Malaria research funding uneven and inequitable, Europe's plan to combat AMR, and unverified malaria medicines on the global market

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Gabe Bienczycki
Research Roundup: Malaria and bone density, a fatal vaccine error, and a sponsored Chikungunya trial

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
WHO/L. Cipriani
WHA Roundup: a new WHO head, the demise of an R&D pooled fund, and the access debate rages on

The 70th World Health Assembly (WHA) winds to a close with key decisions that will shape the future of the World Health Organization (WHO) and the landscape for global health R&D.

Read More
U.S. Mission Photo/Eric Bridiers
Who will lead WHO and what to watch at WHA

With the 70th World Health Assembly (WHA) commencing next week, GHTC takes a look at what's on the agenda and how it could impact global health R&D.

Read More
PATH/Jared Wilmoth
​G20: Connecting the dots on global health innovation, sustainable development, and health security

On April 28, senior leaders from government, the private sector, and the global health community came together in Berlin for a lively discuss on how the G20 can advance global health innovation to drive sustainable development and health security.

Read More
GHTC/Matt Robinson
WHO Executive Board meeting closes with three shortlisted candidates to lead WHO and R&D issues added to WHA agenda

The 140th session of the World Health Organization (WHO) Executive Board closed last week with a shortlist of  three candidates for the WHO Director General position and progress on key global health R&D issues.

Read More
PATH/Patrick McKern
WHO begins process to establish an essential diagnostics list following calls by GHTC and partners

We asked. WHO listened. The World Health Organization (WHO) took the first step toward establishing an essential diagnostics list, releasing a proposal outling how it plans to develop and operationalize the list by early 2019.

Read More
GHTC
The world keeps turning: WHO’s 140th Executive Board meeting begins

With the 140th World Health Organization (WHO) Executive Board meeting commencing this week, GHTC takes a look at what's on the agenda and how it could impact global health R&D.

Read More
PATH/Dunia Faulx
A year in review: The top stories in global health innovation that shaped 2016

As the year comes to an end, GHTC is reflecting on the top stories in global health innovation that made news 2016. 

GHTC
Read More
PATH/Gena Morgan
Why GHTC is joining the call for an essential diagnostics list

An essential diagnostic list list in a smart, cost-effective idea that could advance diagnostic R&D and access.

Read More
David Jacobs
Research Roundup: Pharmaceutical waste and superbugs, resistance to insecticides, and vaccines for crises

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Robin Biellik
Research Roundup: Diagnostics to combat antimicrobial resistance, vaccines for pandemic threats, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Research Roundup: A cancer fighting parasite, drug resistance among STIs and fungi, and a first-of-its-kind virus

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
National Institute of Allergy and Infectious Diseases
Research Roundup: Update on Zika R&D

In this regular feature on Breakthroughs, we highlight the most promising Zika virus vaccine, drug, and diagnostic candidates as well as vector control approaches. 

GHTC
Read More
Sanofi Pasteur / Patrick Boulen
Yellow fever: Status of research, development, and access to countermeasures against an emerging epidemic

GHTC breaks down the status of R&D for vaccines, drugs, and diagnostics against yellow fever.

GHTC
Read More
PATH/Gabe Bienczycki
Research Roundup: Schistosomiasis drug resistance, a nanotechnology vaccine platform, and adjusting doses to bolster the yellow fever vaccine supply

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
GHTC/Matthew Robinson
One week of WHA, extensive debate, and two key R&D decisions

As happens every May, the World Health Organization’s (WHO) highest governing body, the World Health Assembly (WHA), met last week for its 69th annual meeting in Geneva, Switzerland. The agenda was the most packed in recent memory, consisting of more than 70 discussion items, many of which were controversial. Despite the lengthy agenda and difficult conversations, the WHA made two key decisions impacting global health research and development (R&D).

Read More
PATH
Research Roundup: Antimicrobial R&D, pandemic insurance, and Zika countermeasures

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
WHO
WHO's doing WHA for the 69th time next week!

This coming week the “who’s who” of the global health community (as well as some much more modest global health advocates such as your humble author) will make the annual trek to Geneva, Switzerland, for the 69th World Health Assembly (WHA), where World Health Organization (WHO) member states will collectively decide WHO’s plans for the coming year.

Read More
Better together? Five takeaways on the proposal for a WHO pooled fund

Last week, GHTC convened a panel of experts to dissect and discuss a proposal for pooled funding for global health research and development (R&D).

Read More
WHO says “no thanks” to the private sector

There’s an old adage about political negotiating: “You need to be in the room when things are happening if you want to have an impact.”

Read More
WHO Board addresses health R&D, sets March meeting to discuss CEWG resolution

Over 1,000 attendees, a longer than ever agenda—with time management by a song for punishment and a chocolate Caramello Koala as a reward—the 138th World Health Organization (WHO) Executive Board (EB), chaired with humor and efficiency by Precious Matsoso, Director-General of the Department of Health, South Africa, concluded Saturday, January 30 after six days of discussion and debate.

GHTC
Read More
Research Roundup: a new contraceptive option, China’s role in global health R&D, and vaccines for MERS and pneumonia

Last week, GHTC member PATH launched the Caya® contoured diaphragm in the United States, after developing and testing nearly 200 prototypes to ensure the product was safe, effective, and user friendly.

GHTC
Read More
PATH/Nguyen Ba Quang
Research Roundup: Middle East Respiratory Syndrome R&D, G7 support for antimicrobial and neglected tropical disease R&D, patient safety and the 21st Century Cures Act, and the contraceptive pipeline

The zoonotic Middle East Respiratory Syndrome (MERS), which World Health Organization (WHO) Director-General Dr. Margaret Chan called “a threat to the entire world” has spread to South Korea. More than 100 cases and 10 deaths have been reported, making it the largest outbreak outside of the Arabian Peninsula.

GHTC
Read More
World Health Assembly roundup: News on global health research and innovation

The 68th World Health Assembly (WHA) in Geneva wrapped up last week after addressing several items that will shape the next few years of global health innovation.

GHTC
Read More
Research Roundup: priority review voucher sells for record price, WHO action to address antimicrobial resistance, and more

The French pharmaceutical company Sanofi purchased a priority review voucher (PRV)—which entitles the owner to an expedited review of a future product by the US Food and Drug Administration (FDA)—for US$245 million last week.

GHTC
Read More
PATH/Patrick McKern
Research Roundup: publication of clinical trial results, the establishment of an African CDC, and more

The World Health Organization (WHO) released a statement last week calling for the publication of all data from clinical trials for drugs, vaccines, and medical devices.

GHTC
Read More
PATH/Gabe Bienczycki
Research Roundup: India to expand list of essential medicines, China’s emerging leadership in the pharmaceutical industry, WHO paves the way for hepatitis C generics, and more

India is expected to add all of the drugs currently used in the government’s HIV/AIDS and tuberculosis (TB) control programs to its list of essential medicines within the next six months.

GHTC
Read More
PATH/Evelyn Hockstein
GHTC briefing highlights importance of global health innovation in protecting US and world from threats like Ebola

On Thursday, March 26, 2015, the Global Health Technologies Coalition (GHTC) launched its sixth annual policy report titled Meeting the challenge, seizing the opportunity: US leadership can advance global health R&D with a luncheon and panel discussion on Capitol Hill.

GHTC
Read More
WHO Executive Board agrees on set-up of pooled fund for global health R&D

In this guest post, Alexandra Heumber—head of policy affairs at the Drugs for Neglected Diseases initiative—discusses actions taken during the World Health Organization (WHO)’s Executive Board meeting which could impact financing for the research and development (R&D) of new health technologies for developing countries.

Read More
PATH/Gabe Bienczycki
Research Roundup: MenAfriVac® prequalification, an innovative new antibiotic, Ebola vaccine trials, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Evelyn Hockstein
Research Roundup: Saving Lives at Birth, US-Africa Leaders Summit, possible Ebola vaccine, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
Investing in global health innovation=smart power

During the past year, leaders from the US Global Leadership Coalition (USGLC)—an advocacy organization promoting diplomacy and development—have traveled across America seeking out innovators and innovations that best demonstrate how strategic US investments in global development can enhance America’s foreign policy and security interests—an approach USGLC calls “smart power” diplomacy.

Read More
PATH/Satvir Malhotra
CSIS panel: R&D fundamental to meeting new global TB targets

The development of new diagnostic, treatment, and prevention products is fundamental to accelerating the decline of the global tuberculosis (TB) burden, panelists from the World Health Organization (WHO), the National Institutes of Health (NIH), and the Bill & Melinda Gates Foundation agreed on during a panel discussion hosted by the Center for Strategic and International Studies (CSIS) on Monday.

Read More
Why R&D matters for maternal and child health

In this guest post, Sarah Alexander—director of external relations for the Global Alliance to Prevent Prematurity and Stillbirth (GAPPS)—writes about the groundswell of momentum surrounding maternal and child health and the role research and development (R&D) can play in helping more babies have a healthy start to life.

Read More
PATH/Evelyn Hockstein
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
World Health Assembly roundup: News on research and innovation

The annual World Health Assembly (WHA) has come and gone once again, and this time there’s a lot of exciting news to report on the innovation front.

GHTC
Read More
PATH/Evelyn Hockstein
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Satvir Malhotra
Global Health Security—A Priority for All

The US government’s recent commitment to global health security recognizes that health security is an essential part of every nation’s national security. As both Department of Health and Human Services Secretary Kathleen Sebelius and CDC Director Tom Frieden have said, “A health threat anywhere is a health threat everywhere.”

Read More
PATH/Patrick McKern
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
What we’re looking forward to in 2014

As 2014 gets into full swing, the GHTC is looking ahead to many exciting developments on both the global health research and development (R&D) and policy landscapes:

GHTC
Read More
New tool to understand global health regulatory requirements

In this guest post, Tricia Aung—the GHTC’s regulatory associate—writes about a new database that provides easy access to information on global health regulatory information.

GHTC
Read More
PATH/Wendy Stone
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More